Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...
A study conducted by a team of researchers from the Epilepsy Society, including Professor Sanjay Sisodyia and Angeliki Vakrinou has been published in the Brain Communications Journal. The study ...